|
|
| | 2,4-Thiazolidinedione, 5-p-methoxybenzylidene- Basic information |
| Product Name: | 2,4-Thiazolidinedione, 5-p-methoxybenzylidene- | | Synonyms: | 2,4-Thiazolidinedione, 5-p-methoxybenzylidene-;NSC 31205;NSC31205;NSC-31205;NSC 31205;2,4-Thiazolidinedione, 5-[(4-methoxyphenyl)methylene]-;5-[(4-Methoxyphenyl)methylidene]-1,3-thiazolidine-2,4-dione;Pim-1/2 kinase inhibitor 1;2,4 Thiazolidinedione, 5 p methoxybenzylidene ,2,4Thiazolidinedione, 5pmethoxybenzylidene | | CAS: | 6320-51-0 | | MF: | C11H9NO3S | | MW: | 235.26 | | EINECS: | | | Product Categories: | | | Mol File: | 6320-51-0.mol |  |
| | 2,4-Thiazolidinedione, 5-p-methoxybenzylidene- Chemical Properties |
| form | Solid | | color | Light yellow to yellow |
| | 2,4-Thiazolidinedione, 5-p-methoxybenzylidene- Usage And Synthesis |
| Uses | Pim-1/2 kinase inhibitor 1 is an orally active pim-1/2 kinase inhibitor. Pim-1/2 kinase inhibitor 1 blocks the ability of Pim kinases to phosphorylate peptides, and inhibits the pim protein kinase directed phosphorylation of 4E-BP1 and p27Kip1. Pim-1/2 kinase inhibitor 1 can be used in study of cancer, especially prostate cancer[1]. | | References | [1] Charles D. Smith, et al. Inhibitors of PIM-1 Protein Kinases, Compositions and Methods for Treating Prostate Cancer. Patent US20110263664A1. |
| | 2,4-Thiazolidinedione, 5-p-methoxybenzylidene- Preparation Products And Raw materials |
|